Making C-I Medical a Consolidated Subsidiary and Taking It Private
First written in FY2026-H1. 1 of 2 entries say "Achieved", first in FY2026-H1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Cited as achievedAnnual report
「The tender offer for shares of 歯愛メディカル, announced on 7 August 2025, was completed, and the company additionally acquired shares in the company on 14 October of the same year. As a result, the company's voting rights ownership increased from 38.29% to 78.65%, making 歯愛メディカル a consolidated subsidiary.」
It again reports the completion of the series of transactions involving C.I.A. Medical, including the successful TOB, additional acquisition, conversion into a consolidated subsidiary, and delisting, citing this as a past achievement in advancing synergies beyond the dental and medical fields, DX, and long-term investment across the Group. - FY2026-H1AchievedAnnual report
「The tender offer (TOB) for C.I.A. Medical Co., Ltd., announced by the Company on 7 August 2025, was successful, and the Company acquired additional shares in the company on 14 October of the same year. As a result, the Company's voting-rights ownership increased from 38.29% to 78.65%, making the company a consolidated subsidiary. Consequently, the company's shares became subject to the Tokyo Stock Exchange's delisting criteria and were delisted from the Standard Market of the Tokyo Stock Exchange effective 15 December 2025.」
For 歯愛メディカル, with which the company had a capital and business alliance since 2016, additional acquisitions following the tender offer increased the voting rights ownership ratio from 38.29% to 78.65%. The company made it a consolidated subsidiary on 14 October 2025 and delisted it on 15 December. The company has stated that its aim is to advance long-term investment, DX and growth strategies across the Group, in addition to its dental and medical businesses.